NCT03347617 2025-09-09
Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma
OHSU Knight Cancer Institute
Phase 2 Terminated
Clinical Trials
5 trialsNCT00659126 2023-09-07
Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain Tumors
OHSU Knight Cancer Institute
Phase 2 Terminated
NCT00978562 2022-08-03
DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain Tumors
OHSU Knight Cancer Institute
Phase EARLY_PHASE1 Completed
NCT00103038 2022-06-09
Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases
OHSU Knight Cancer Institute
Phase NA Completed
NCT00660543 2017-05-16
MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy
OHSU Knight Cancer Institute
Phase NA Completed